Neurological Biomarkers Market Size, Share, Trends, Growth, and Regional Forecasts 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Neurological Biomarkers Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Neurological Biomarkers Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Neurological Biomarkers Market Outlook: Biomarkers
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Biomarker, 2019-2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
         1. Proteomic Biomarkers
         2. Genomic Biomarkers
         3. Neuroimaging Biomarkers
         4. Metabolomics Biomarkers
      4. Market Attractiveness Analysis: Biomarkers
   4. Global Neurological Biomarkers Market Outlook: Sample
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Sample, 2019-2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
         1. Blood
         2. Plasma
         3. Cerebrospinal Fluid
         4. Others 
      4. Market Attractiveness Analysis: Sample
   5. Global Neurological Biomarkers Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
         1. Alzheimer's Disease (AD)
         2. Multiple Sclerosis (MS)
         3. Parkinson's Disease (PD)
         4. Autism Spectrum Disorder (ASD)
         5. Others
      4. Market Attractiveness Analysis: Indication
   6. Global Neurological Biomarkers Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
         1. Hospital Labs
         2. Diagnostic Centers
         3. Academic & Research Institutes
         4. Biopharma Companies
         5. Proteomic Laboratory
         6. Others
      4. Market Attractiveness Analysis: End-user
5. Global Neurological Biomarkers Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
      7. Market Attractiveness Analysis: Region
6. North America Neurological Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Biomarker
      3. By Sample
      4. By Indication
      5. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
      1. Proteomic Biomarkers
      2. Genomic Biomarkers
      3. Neuroimaging Biomarkers
      4. Metabolomics Biomarkers
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
      1. Blood
      2. Plasma
      3. Cerebrospinal Fluid
      4.  Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Alzheimer's Disease (AD)
      2. Multiple Sclerosis (MS)
      3. Parkinson's Disease (PD)
      4. Autism Spectrum Disorder (ASD)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospital Labs
      2. Diagnostic Centers
      3. Academic & Research Institutes
      4. Biopharma Companies
      5. Proteomic Laboratory
      6. Others
   8. Market Attractiveness Analysis
7. Europe Neurological Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Biomarker
      3. By Sample
      4. By Indication
      5. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
      1. Proteomic Biomarkers
      2. Genomic Biomarkers
      3. Neuroimaging Biomarkers
      4. Metabolomics Biomarkers
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
      1. Blood
      2. Plasma
      3. Cerebrospinal Fluid
      4.  Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Alzheimer's Disease (AD)
      2. Multiple Sclerosis (MS)
      3. Parkinson's Disease (PD)
      4. Autism Spectrum Disorder (ASD)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospital Labs
      2. Diagnostic Centers
      3. Academic & Research Institutes
      4. Biopharma Companies
      5. Proteomic Laboratory
      6. Others
   8. Market Attractiveness Analysis
8. East Asia Neurological Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Biomarker
      3. By Sample
      4. By Indication
      5. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
      1. Proteomic Biomarkers
      2. Genomic Biomarkers
      3. Neuroimaging Biomarkers
      4. Metabolomics Biomarkers
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
      1. Blood
      2. Plasma
      3. Cerebrospinal Fluid
      4.  Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Alzheimer's Disease (AD)
      2. Multiple Sclerosis (MS)
      3. Parkinson's Disease (PD)
      4. Autism Spectrum Disorder (ASD)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospital Labs
      2. Diagnostic Centers
      3. Academic & Research Institutes
      4. Biopharma Companies
      5. Proteomic Laboratory
      6. Others
   8. Market Attractiveness Analysis
9. South Asia & Oceania Neurological Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Biomarker
      3. By Sample
      4. By Indication
      5. By End-user
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
      1. Proteomic Biomarkers
      2. Genomic Biomarkers
      3. Neuroimaging Biomarkers
      4. Metabolomics Biomarkers
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
      1. Blood
      2. Plasma
      3. Cerebrospinal Fluid
      4.  Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Alzheimer's Disease (AD)
      2. Multiple Sclerosis (MS)
      3. Parkinson's Disease (PD)
      4. Autism Spectrum Disorder (ASD)
      5. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      1. Hospital Labs
      2. Diagnostic Centers
      3. Academic & Research Institutes
      4. Biopharma Companies
      5. Proteomic Laboratory
      6. Others
   8. Market Attractiveness Analysis
10. Latin America Neurological Biomarkers Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Biomarker
       3. By Sample
       4. By Indication
       5. By End-user
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
       1. Proteomic Biomarkers
       2. Genomic Biomarkers
       3. Neuroimaging Biomarkers
       4. Metabolomics Biomarkers
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
       1. Blood
       2. Plasma
       3. Cerebrospinal Fluid
       4.  Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
       1. Alzheimer's Disease (AD)
       2. Multiple Sclerosis (MS)
       3. Parkinson's Disease (PD)
       4. Autism Spectrum Disorder (ASD)
       5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
       1. Hospital Labs
       2. Diagnostic Centers
       3. Academic & Research Institutes
       4. Biopharma Companies
       5. Proteomic Laboratory
       6. Others
    8. Market Attractiveness Analysis
11. Middle East & Africa Neurological Biomarkers Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Biomarker
       3. By Sample
       4. By Indication
       5. By End-user
    3. Current Market Size (US$ Mn) and Forecast, By Country, 2025-2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025-2032
       1. Proteomic Biomarkers
       2. Genomic Biomarkers
       3. Neuroimaging Biomarkers
       4. Metabolomics Biomarkers
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2025-2032
       1. Blood
       2. Plasma
       3. Cerebrospinal Fluid
       4.  Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
       1. Alzheimer's Disease (AD)
       2. Multiple Sclerosis (MS)
       3. Parkinson's Disease (PD)
       4. Autism Spectrum Disorder (ASD)
       5. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
       1. Hospital Labs
       2. Diagnostic Centers
       3. Academic & Research Institutes
       4. Biopharma Companies
       5. Proteomic Laboratory
       6. Others
    8. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Quanterix
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Amoneta Diagnostics
       3. Bio-Rad Laboratories, Inc
       4. Eli Lilly and Company
       5. IXICO plc
       6. Biognosys
       7. Revvity
       8. Beckman Coulter, Inc.
       9. PreOmics GmbH
       10. ADx NeuroSciences NV (A Fujirebio Company)
       11. Fujirebio
       12. Brainomix
       13. Merck KGaA
       14. Bio-Techne
       15. Assay Genie
       16. SomaLogic Operating Co., Inc.
       17. Siemens Healthineers
       18. Abbott Laboratories
       19. Roche Diagnostics
       20. GE HealthCare
       21. Imaging Endpoints 
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations